-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Chromocell Therapeutics Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2023 to Q3 2024.
- Chromocell Therapeutics Corp Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.69M, a 19.2% decline year-over-year.
- Chromocell Therapeutics Corp Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$10.1M.
- Chromocell Therapeutics Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$7.38M, a 200% decline from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)